A vaccine to combat diarrheal deaths in India. A bed net to protect against malaria in Malawi. A diagnostic to identify dengue in Honduras. These lifesaving tools are examples of the impact of US government investment in global health research and development (R&D). But you may be surprised to learn that jobs in New Jersey, economic growth in Georgia, and protection against health threats in Texas should also be added to this list. US-funded global health R&D is advancing innovations that are improving health worldwide while also paying huge dividends for America and in each state.
Join us for a dialogue and briefing to launch a new state-by-state analysis from GHTC examining how global health R&D delivers economic and health benefits across US states and discuss how we can leverage these findings to advance US support for global health innovation in uncertain times.
Lunch will be provided. This event is free and open to the public, and the invitation has been widely distributed in compliance with congressional ethics rules.